The human immunoglobulin (PH4) for intravenous injection market is anticipated to grow at a significant CAGR of 12.7% during the forecast period (2022-2028). Immunoglobins or antibodies are mainly produced by plasma cells which are glycoprotein molecules. They work against various types of antigenic stimuli which are involved in the body to carry out physiological and pathological processes. […]
